Abstract. Although aesthetics is recognized as a reason for the protection of biodiversity, comparatively little weight has been accorded to the grandeur o

Rukhlenko, O. S. et al. Control of cell state transitions. Nature 609, 975–985 (2022). Schaffer, L. V. & Ideker, T. Mapping the multiscale structure of biological systems. Cell Syst. 12, 622–635 (2021). Chaudhuri, S. & Srivastava, A. Network approach to understand biological systems: from single to multilayer networks. J. Biosci. 47, 55 (2022). Pei, G., Lyons, H., Li, P. & Sabari, B. R. Transcription regulation by biomolecular condensates. Nat. Rev. Mol. Cell Biol. 26, 213–236 (2025). Choquet, K., Patop, I. L. & Churchman, L. S. The regulation and function of post-transcriptional RNA splicing. Nat. Rev. Genet. 26, 378–394 (2025). Curtis, D., Lehmann, R. & Zamore, P. D. Translational regulation in development. Cell 81, 171–178 (1995). Mann, M. & Jensen, O. N. Proteomic analysis of post-translational modifications. Nat. Biotechnol. 21, 255–261 (2003). Damgaard, R. B. The ubiquitin system: from cell signalling to disease biology and new therapeutic opportunities. Cell Death Differ. 28, 423–426 (2021). Castro-Muñoz, L. J. et al. Modulating epigenetic modifications for cancer therapy (Review). Oncol. Rep. 49, 59 (2023). Zhou, G., Li, S. & Xia, J. Network-based approaches for multi-omics integration. In Computational Methods and Data Analysis for Metabolomics (ed. Li, S.) 469–487 (Springer, 2020). Hasin, Y., Seldin, M...

The Department of Developmental and Cell Biology seeks discoveries that foster a better understanding of biological questions such as the origins of cancer development, cell repair and regrowth and de...

Abstract. Earth’s climate system is moving deeper into uncharted territory. We present the 2026 update of planetary vital signs that track the state of Ear

Key Points Pulse Biosciences partnered with the Clayman Thyroid Center in Tampa for commercial use and clinical research involving its nPulse Vybrance Syst

Colombo, R., Tarantino, P., Rich, J. R., LoRusso, P. M. & de Vries, E. G. E. The journey of antibody-drug conjugates: lessons learned from 40 years of development. Cancer Discov. 14, 2089–2108 https://doi.org/10.1158/2159-8290.CD-24-0708 (2024). Peters, C. & Brown, S. Antibody-drug conjugates as novel anti-cancer chemotherapeutics. Biosci. Rep. 35, e00225 https://doi.org/10.1042/BSR20150089 (2015). McNamee, N. J., Liu, J., Poulos, R. C., Aref, A. T. & Reddel, R. R. Predictive biomarkers of antibody-drug conjugate efficacy for solid tumors: current challenges and the potential role of quantitative proteomics. Clin. Cancer Res. 32, 661–673 https://doi.org/10.1158/1078-0432.CCR-25-3103 (2026). Drago, J. Z., Modi, S. & Chandarlapaty, S. Unlocking the potential of antibody-drug conjugates for cancer therapy. Nat. Rev. Clin. Oncol. 18, 327–344 https://doi.org/10.1038/s41571-021-00470-8 (2021). Vogel, M., Colombo, R. & Tarantino, P. Beyond the guided missile paradigm: embracing the complexity of antibody-drug conjugates. J. Clin. Oncol. 43, 3339–3344 https://doi.org/10.1200/JCO-25-01235 (2025). Fang, J. et al. The target atlas for antibody-drug conjugates across solid cancers. Cancer Gene Ther. 31, 273–284 https://doi.org/10.1038/s41417-023-00701-3 (2024). Meric-Bernstam, F. et al. Efficacy and safety of trastuzumab deruxtecan in patients with HER2-expressing solid tumors: primary results from the DESTINY-PanTumor02 phase II trial. J. Clin. Oncol. 42, 47–58 https://doi.org/10.1200/JCO.23.02005 (2024). Liu, J. et al. Tumor-agnostic therapies: translating scientific...